![Adam Willis Perriman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Adam Willis Perriman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cytoseek Ltd.
![]() Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Director/Miembro de la Junta | 22/11/2017 | - |
Fundador | 22/11/2017 | - |
Historial de carrera de Adam Willis Perriman
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Director/Board Member | 1 |
Founder | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Cytoseek Ltd.
![]() Cytoseek Ltd. Miscellaneous Commercial ServicesCommercial Services Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Adam Willis Perriman
- Experiencia